Held on 26 October 2016
Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held on 26 October 2016 have transacted the following -The Board informed that Bliss GVS Healthcare, the Kenyan step down subsidiary of the Company has won an Annual Contract worth USD 38.76 million for a period of two years, from a consortium of leading insurance firms in Kenya for provision of in-patient and out-patient health care services for approximately 125000 principle members and their dependents.
The Board also approved the terms and conditions of the loan proposal of Rs 68 crore from IDFC/ ICBC Bank. The Board forwarded the loan proposal for review of audit committee.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content